Atlas Trials

Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402

Clinical trial NCT03921268 · COMPLETED

Trial details

NCT number
NCT03921268
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Asthma
Start date
2019-03-25
Primary completion
2019-06-13
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.